查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1672119

全球癌症免疫疗法药物研发外包市场研究报告-产业分析、规模、份额、成长、趋势及预测 2025 年至 2033 年

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

全球癌症免疫疗法药物研发外包市场规模预计将从 2024 年的 20.9 亿美元增长到 2033 年的 50.8 亿美元，在 2026 年至 2033 年的预测期内呈现 10.42% 的强劲年复合成长率(CAGR)。

受创新癌症治疗需求不断增长和药物开发过程日益复杂化的推动，癌症免疫治疗药物研发外包市场有望大幅成长。免疫疗法已成为一种很有前途的癌症治疗方法，它利用人体的免疫系统来瞄准和摧毁癌细胞。随着製药公司寻求加快药物研发力度并降低成本，免疫疗法研发活动的外包变得越来越普遍，这使得该市场有望强劲扩张。

此外，免疫疗法技术的进步正在推动市场创新。单株抗体、CAR-T 细胞疗法和免疫检查点抑制剂等新型治疗剂的开发正在彻底改变癌症治疗并为外包合作创造新的机会。这些创新不仅提高了癌症治疗的疗效，而且还需要专业知识和资源，因此外包对于许多组织来说是一个有吸引力的选择。随着研究不断探索新的免疫疗法和联合疗法，癌症免疫治疗药物发现外包市场可能会进一步扩大，这得益于改善患者治疗效果和加快药物开发时间表的前景。

此外，对合作和策略伙伴关係的日益重视正在塑造癌症免疫疗法药物研发外包格局。随着利害关係人认识到利用外部专业知识和资源的价值，製药公司和合约研究组织（CRO）之间的联盟形成变得越来越普遍。这些合作关係使公司能够获得专业知识、先进技术和高效流程，从而增强药物研发管道。随着癌症免疫疗法药物研发外包市场不断发展，对合作和创新的关注将在推动其未来成长中发挥关键作用。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：癌症免疫治疗药物研发外包产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按服务类型分析市场吸引力
    • 按癌症类型进行市场吸引力分析
    • 按药物类型分析市场吸引力
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球癌症免疫疗法药物发现外包市场分析：按服务类型

  • 依服务类型概览
  • 按服务类型进行的历史和预测资料分析
  • 目标识别与验证
  • 先导物筛选与表征
  • 基于细胞的检测

第 6 章：全球癌症免疫疗法药物发现外包市场分析：按癌症类型

  • 癌症类型概览
  • 按癌症类型进行的历史和预测数据分析
  • 肺
  • 胸部
  • 大肠直肠
  • 黑色素瘤
  • 摄护腺
  • 头部和颈部
  • 卵巢
  • 胰

第 7 章：全球癌症免疫疗法药物发现外包市场分析：按药物类型

  • 依药物类型概览
  • 按药物类型进行的历史和预测数据分析
  • 单株抗体
  • 免疫调节剂
  • 癌症疫苗和溶瘤病毒疗法
  • 其他的

第 8 章：全球癌症免疫疗法药物发现外包市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 9 章：癌症免疫疗法药物研发外包公司的竞争格局

  • 癌症免疫疗法药物研发外包市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第十章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Covance Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Explicyte
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Aquila BioMedical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Horizon Discovery Group PLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Crown Bioscience Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Promega Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • HD Biosciences Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BPS Bioscience Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Genscript Biotech Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • DiscoverX Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Celentyx Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ImmunXperts SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Personalis Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • STC Biologics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Molecular Imaging Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11211227

Global Cancer Immunotherapy Drug Discovery Outsourcing Market size is anticipated to grow from USD 2.09 Billion in 2024 to USD 5.08 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.42% during the forecast period of 2026 to 2033.

The cancer immunotherapy drug discovery outsourcing market is poised for significant growth, driven by the increasing demand for innovative cancer treatments and the rising complexity of drug development processes. Immunotherapy has emerged as a promising approach to cancer treatment, harnessing the body's immune system to target and destroy cancer cells. As pharmaceutical companies seek to accelerate their drug discovery efforts and reduce costs, the outsourcing of immunotherapy research and development activities is becoming increasingly common, positioning this market for robust expansion.

Moreover, advancements in immunotherapy technologies are driving innovation within the market. The development of novel therapeutic agents, such as monoclonal antibodies, CAR-T cell therapies, and immune checkpoint inhibitors, is revolutionizing cancer treatment and creating new opportunities for outsourcing partnerships. These innovations not only enhance the efficacy of cancer therapies but also require specialized expertise and resources, making outsourcing an attractive option for many organizations. As research continues to explore new immunotherapeutic approaches and combination therapies, the cancer immunotherapy drug discovery outsourcing market is likely to expand further, driven by the promise of improved patient outcomes and accelerated drug development timelines.

Additionally, the growing emphasis on collaboration and strategic partnerships is shaping the cancer immunotherapy drug discovery outsourcing landscape. As stakeholders recognize the value of leveraging external expertise and resources, the formation of alliances between pharmaceutical companies and contract research organizations (CROs) is becoming more prevalent. These partnerships enable companies to access specialized knowledge, advanced technologies, and efficient processes that can enhance the drug discovery pipeline. As the cancer immunotherapy drug discovery outsourcing market continues to evolve, the focus on collaboration and innovation will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Service Type

  • Target Identification and Validation
  • Lead Screening and Characterization
  • Cell-based Assays

By Cancer Type

  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head and Neck
  • Ovarian
  • Pancreatic

By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Cancer Vaccines and Oncolytic Viral Therapy
  • Others
  • COMPANIES PROFILED
  • Covance Inc.
  • Explicyte
  • Aquila BioMedical
  • Horizon Discovery Group PLC
  • Crown Bioscience Inc.
  • Promega Corporation
  • HD Biosciences Co. Ltd.
  • BPS Bioscience Inc.
  • Genscript Biotech Corporation
  • DiscoverX Corporation
  • Celentyx Ltd.
  • ImmunXperts SA
  • Personalis Inc.
  • STC Biologics
  • Molecular Imaging Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By Cancer Type
    • 3.7.3 Market Attractiveness Analysis By Drug Type
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

  • 5.1. Overview By Service Type
  • 5.2. Historical and Forecast Data Analysis By Service Type
  • 5.3. Target Identification and Validation Historic and Forecast Sales By Regions
  • 5.4. Lead Screening and Characterization Historic and Forecast Sales By Regions
  • 5.5. Cell-based Assays Historic and Forecast Sales By Regions

6. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

  • 6.1. Overview By Cancer Type
  • 6.2. Historical and Forecast Data Analysis By Cancer Type
  • 6.3. Lung Historic and Forecast Sales By Regions
  • 6.4. Breast Historic and Forecast Sales By Regions
  • 6.5. Colorectal Historic and Forecast Sales By Regions
  • 6.6. Melanoma Historic and Forecast Sales By Regions
  • 6.7. Prostate Historic and Forecast Sales By Regions
  • 6.8. Head and Neck Historic and Forecast Sales By Regions
  • 6.9. Ovarian Historic and Forecast Sales By Regions
  • 6.10. Pancreatic Historic and Forecast Sales By Regions

7. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

  • 7.1. Overview By Drug Type
  • 7.2. Historical and Forecast Data Analysis By Drug Type
  • 7.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 7.4. Immunomodulators Historic and Forecast Sales By Regions
  • 7.5. Cancer Vaccines and Oncolytic Viral Therapy Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

  • 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Covance Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Explicyte
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Aquila BioMedical
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Horizon Discovery Group PLC
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Crown Bioscience Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Promega Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. HD Biosciences Co. Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. BPS Bioscience Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Genscript Biotech Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. DiscoverX Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Celentyx Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. ImmunXperts SA
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Personalis Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. STC Biologics
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Molecular Imaging Inc
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service Type (USD MN)
  • Target Identification and Validation Market Sales By Geography (USD MN)
  • Lead Screening and Characterization Market Sales By Geography (USD MN)
  • Cell-based Assays Market Sales By Geography (USD MN)
  • Analysis By Cancer Type (USD MN)
  • Lung Market Sales By Geography (USD MN)
  • Breast Market Sales By Geography (USD MN)
  • Colorectal Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Prostate Market Sales By Geography (USD MN)
  • Head and Neck Market Sales By Geography (USD MN)
  • Ovarian Market Sales By Geography (USD MN)
  • Pancreatic Market Sales By Geography (USD MN)
  • Analysis By Drug Type (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Immunomodulators Market Sales By Geography (USD MN)
  • Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Cancer Type
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Service Type (USD MN)
  • Target Identification and Validation Market Sales By Geography (USD MN)
  • Lead Screening and Characterization Market Sales By Geography (USD MN)
  • Cell-based Assays Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer Type (USD MN)
  • Lung Market Sales By Geography (USD MN)
  • Breast Market Sales By Geography (USD MN)
  • Colorectal Market Sales By Geography (USD MN)
  • Melanoma Market Sales By Geography (USD MN)
  • Prostate Market Sales By Geography (USD MN)
  • Head and Neck Market Sales By Geography (USD MN)
  • Ovarian Market Sales By Geography (USD MN)
  • Pancreatic Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Type (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Immunomodulators Market Sales By Geography (USD MN)
  • Cancer Vaccines and Oncolytic Viral Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.